| scholarly article | Q13442814 |
| P50 | author | Andrew N Phillips | Q87677848 |
| Jens Lundgren | Q42325404 | ||
| Martyn A. French | Q55536074 | ||
| P2093 | author name string | Álvaro H Borges | |
| Jemma L O'Connor | |||
| Michael J Vjecha | |||
| Sarah Pett | |||
| Frederikke F Rönsholt | |||
| INSIGHT SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee | |||
| P2860 | cites work | A new equation to estimate glomerular filtration rate | Q24651973 |
| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 | ||
| Inflammation, coagulation and cardiovascular disease in HIV-infected individuals | Q28483645 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| CD4+ count-guided interruption of antiretroviral treatment | Q29619489 | ||
| From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. | Q30361595 | ||
| Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections | Q30558355 | ||
| Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. | Q32131424 | ||
| Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer | Q33488630 | ||
| HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality | Q33618542 | ||
| Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers | Q33713347 | ||
| Interleukin-2 therapy in patients with HIV infection | Q33847543 | ||
| Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection | Q33857515 | ||
| Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV | Q69735133 | ||
| Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study | Q73555669 | ||
| Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly | Q77769291 | ||
| Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus | Q78095358 | ||
| HIV Infection, Inflammation, Immunosenescence, and Aging | Q34150710 | ||
| Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. | Q34449273 | ||
| Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems | Q34677793 | ||
| Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation | Q35021902 | ||
| Factors associated with D-dimer levels in HIV-infected individuals | Q35120065 | ||
| Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study | Q35156330 | ||
| Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial | Q35629714 | ||
| Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease | Q35842424 | ||
| The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis | Q35864053 | ||
| HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation | Q36383621 | ||
| Interleukin-6 and the acute phase response | Q36559880 | ||
| Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir | Q36578046 | ||
| Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy | Q36937853 | ||
| Role of interleukin-6 in the anemia of chronic disease | Q37108951 | ||
| Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma | Q37434973 | ||
| Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage | Q37845554 | ||
| The biology and medical implications of interleukin-6. | Q38207010 | ||
| Association of inflammatory cytokines and endothelial adhesion molecules with immunological, virological, and cardiometabolic disease in HIV-infected individuals | Q39155707 | ||
| Circulating IL-6 concentrations and associated anthropometric and metabolic parameters in South Asian men and women in comparison to European whites | Q39544417 | ||
| Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study | Q42216734 | ||
| Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women | Q44177937 | ||
| Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency | Q44271055 | ||
| Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma | Q44941158 | ||
| Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study | Q45389079 | ||
| Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation | Q46157814 | ||
| Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. | Q51350972 | ||
| Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. | Q51557638 | ||
| IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation | Q56943138 | ||
| Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo | Q57079498 | ||
| Cigarette smoking influences cytokine production and antioxidant defences | Q57659951 | ||
| Hormone Replacement Therapy and Interrelation between Serum Interleukin-6 and Body Mass Index in Postmenopausal Women: A Population-Based Study | Q58043387 | ||
| Body composition changes after switching from protease inhibitors to raltegravir | Q58204659 | ||
| Enhanced inflammatory response in patients with preinfarction unstable angina | Q58230307 | ||
| Infection with HIV is associated with elevated IL-6 levels and production | Q68693896 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 585-595 | |
| P577 | publication date | 2015-02-26 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Factors Associated With Plasma IL-6 Levels During HIV Infection | |
| P478 | volume | 212 |
| Q40051462 | Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings. |
| Q49211453 | Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study. |
| Q40129344 | Cardiovascular outcomes among HIV-infected veterans receiving atazanavir |
| Q60920372 | Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study |
| Q38984209 | Combination antiretroviral therapy and cancer risk |
| Q36822866 | Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study. |
| Q40075058 | Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns |
| Q52672845 | Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy. |
| Q64230450 | Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling |
| Q36956654 | HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox". |
| Q38659387 | HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer |
| Q61799271 | HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses |
| Q36327164 | HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation |
| Q92862018 | High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy |
| Q36931801 | History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke |
| Q40709368 | Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013. |
| Q58093829 | Hypothalamic Inflammation at a Crossroad of Somatic Diseases |
| Q36360872 | Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial |
| Q38711879 | Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls. |
| Q93095942 | Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study |
| Q41989633 | Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? |
| Q40692524 | Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection |
| Q35860942 | Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities |
| Q89771713 | Obesity and Weight Gain in Persons with HIV |
| Q93167174 | Partial Normalization of Biomarkers of Inflammation and Immune Activation Among Virally Suppressed Men With HIV Infection and High ART Adherence |
| Q92529029 | Patho-immune Mechanisms of Hypertension in HIV: a Systematic and Thematic Review |
| Q50276599 | Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of Chikungunya virus infection |
| Q26782493 | Targeting interleukin-6 for noninfectious uveitis |
| Q39276816 | Tenofovir exposure in utero and linear growth in HIV exposed, uninfected infants: a prospective study |
| Q39145435 | Tenofovir exposure in utero and linear growth in HIV-exposed, uninfected infants |
| Q40101352 | The Aging Population with HIV Infection |
| Q90027957 | The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa |
| Q64263684 | The Role of Interleukin 6 During Viral Infections |
| Q36120745 | The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study |
| Q61807325 | Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil |
Search more.